Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition …

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Objective There is an urgent need to assess the impact of immunosuppressive therapies on
the immunogenicity and efficacy of SARS-CoV-2 vaccination. Methods Serological and T …

There is a paucity of data on the effect of antirheumatic drugs on serological responses to
COVID-19 vaccines. Anti-CD20 therapies deplete B-cells, with reconstitution often not …

Introduction To assess the incidence and risk factors for breakthrough COVID-19 infection in
a vaccinated cohort of patients with autoimmune rheumatic diseases (AIRDs) and determine …

SARS-CoV-2 vaccines reduce the risk of COVID-19. 1–3 However, some disease-modifying
anti-rheumatic drugs (DMARDs), particularly glucocorticoids, methotrexate, mycophenolate …

Objective To evaluate the effect on immunogenicity and safety of 2-week methotrexate
(MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine versus MTX …

Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …

Myasthenic crisis (MC) is a life‐threatening manifestation of myasthenia gravis (MG) defined
by respiratory insufficiency that requires the use of invasive or non‐invasive ventilation. This …

Objective With a vaccine effectiveness of 95% for preventing coronavirus disease 2019
(COVID‐19), Pfizer‐BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe …